Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake

OBJECTIVE—Glucagon-like peptide-1 (GLP-1) promotes glucose homeostasis through regulation of islet hormone secretion, as well as hepatic and gastric function. Because GLP-1 is also synthesized in the brain, where it regulates food intake, we hypothesized that the central GLP-1 system regulates glucose tolerance as well. RESEARCH DESIGN AND METHODS—We used glucose tolerance tests and hyperinsulinemic-euglycemic clamps to assess the role of the central GLP-1 system on glucose tolerance, insulin secretion, and hepatic and peripheral insulin sensitivity. Finally, in situ hybridization was used to examine colocalization of GLP-1 receptors with neuropeptide tyrosine and pro-opiomelanocortin neurons. RESULTS—We found that central, but not peripheral, administration of low doses of a GLP-1 receptor antagonist caused relative hyperglycemia during a glucose tolerance test, suggesting that activation of central GLP-1 receptors regulates key processes involved in the maintenance of glucose homeostasis. Central administration of GLP-1 augmented glucose-stimulated insulin secretion, and direct administration of GLP-1 into the arcuate, but not the paraventricular, nucleus of the hypothalamus reduced hepatic glucose production. Consistent with a role for GLP-1 receptors in the arcuate, GLP-1 receptor mRNA was found to be expressed in 68.1% of arcuate neurons that expressed pro-opiomelanocortin mRNA but was not significantly coexpressed with neuropeptide tyrosine. CONCLUSIONS—These data suggest that the arcuate GLP-1 receptors are a key component of the GLP-1 system for improving glucose homeostasis by regulating both insulin secretion and glucose production.

• Publication year

  2008

• Venue

  Diabetes

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db07-1824PMID 18487451PMCID 2494674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of Glucosensing Neuron Subpopulations in the Arcuate Nucleus

  2007cited by this paper
• Glucagon-Like Peptide 1 Stimulates Hypothalamic Proopiomelanocortin Neurons

  2007cited by this paper
• A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release.

  2007cited by this paper
• Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat

  2006cited by this paper
• Regulation of Blood Glucose by Hypothalamic Pyruvate Metabolism

  2005cited by this paper
• Leptin action in the forebrain regulates the hindbrain response to satiety signals.

  2005cited by this paper
• Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.

  2005cited by this paper
• Hypothalamic KATP channels control hepatic glucose production

  2005cited by this paper
• Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

  2005cited by this paper
• Brain region-dependent effects of dexamethasone on counterregulatory responses to hypoglycemia in conscious rats.

  2005cited by this paper
• Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis

  2005cited by this paper
• The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity.

  2005cited by this paper
• Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis

  2004cited by this paper
• Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.

  2004cited by this paper
• Melanocortin-independent Effects of Leptin on Hepatic Glucose Fluxes*

  2004cited by this paper
• The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides.

  2004cited by this paper
• Characterization of [3H]Harmane Binding to Rat Whole Brain Membranes

  2003cited by this paper
• Electrophysiological Actions of Peripheral Hormones on Melanocortin Neurons

  2003cited by this paper
• Hypothalamic proopiomelanocortin neurons are glucose responsive and express K(ATP) channels.

  2003cited by this paper
• Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production

  2003cited by this paper
• Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.

  2003cited by this paper
• CNS Glucagon-Like Peptide-1 Receptors Mediate Endocrine and Anxiety Responses to Interoceptive and Psychogenic Stressors

  2003cited by this paper
• Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons.

  2003cited by this paper
• Cell signalling of the GLP-1 action in rat liver.

  2003cited by this paper
• Central administration of oleic acid inhibits glucose production and food intake.

  2002cited by this paper
• Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier

  2002cited by this paper
• Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats

  2002cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons.

  2002cited by this paper
• The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness

  2002cited by this paper
• Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

  2002cited by this paper
• Hypothalamic insulin signaling is required for inhibition of glucose production

  2002cited by this paper
• Central melanocortin receptors regulate insulin action.

  2001cited by this paper
• Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system

  1999influential reference
• Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.

  1998cited by this paper
• PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.

  1998cited by this paper
• Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.

  1998cited by this paper
• Intracerebroventricular Leptin Regulates Hepatic but Not Peripheral Glucose Fluxes*

  1998cited by this paper
• Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.

  1997cited by this paper
• Glucagon-like peptide-1 and satiety

  1997cited by this paper
• High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor*

  1997cited by this paper
• Glucagon-like peptide-1 and satiety

  1997cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

  1996cited by this paper
• Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

  1996cited by this paper
• Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

  1995cited by this paper
• Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.

  1994cited by this paper
• Glucagon‐like peptide 1: A potent glycogenic hormone

  1994cited by this paper
• Effect of Somatostatin-28 on Dynamics of Insulin Secretion in Perfused Rat Pancreas

  1991cited by this paper
• Glucagon and the Glucagon‐like Peptides

  1990cited by this paper
• Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study

  1988cited by this paper
• Glucagon-like peptide-1 7-36: a physiological incretin in man.

  1987cited by this paper
• Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

  1987cited by this paper
• Cellular localization of proglucagon/glucagon‐like peptide I messenger RNAs in rat brain

  1986cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

  1963cited by this paper
• Effect of insulin on utilization and production of circulating glucose.

  1957cited by this paper
• Diabetes

  1894cited by this paper

• Effects of Semaglutide on BMI and Cardiometabolic Profile in Adolescents With Variants in Monogenic Obesity‐Related Genes

  2026cites this paper
• GLP-1 physiology and pharmacology along the gut-brain axis

  2026cites this paper
• Metformin Boosts Intestinal Lipid Sensing via GIP to Suppress Feeding.

  2025cites this paper
• Psychotropic effects of GLP-1R agonists.

  2025cites this paper
• The interface between the homeostatic and hedonic energy balance circuitries in the regulation of appetitive behavior: A focus on steroidogenic factor-1/pituitary adenylate cyclase-activating polypeptide neurons in the hypothalamic ventromedial nucleus.

  2025cites this paper
• Impact of GLP-1 Receptor Agonists on Perceived Eating Behaviors in Response to Stimuli

  2025cites this paper
• The (dys)regulation of energy storage in obesity.

  2025cites this paper
• Integration of Glucagon-like Peptide 1 Receptor Actions through the Central Amygdala.

  2025cites this paper
• Nmnat2 deficiency in the arcuate nucleus or paraventricular nucleus induces Sarm1‐independent neuron loss and liraglutide‐reversible obesity

  2025cites this paper
• The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review

  2025cites this paper
• Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies

  2025cites this paper
• Glucagon-like peptide 1 (GLP-1) action on hypothalamic feeding circuits.

  2025cites this paper
• Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics

  2024cites this paper
• GLP-1R–positive neurons in the lateral septum mediate the anorectic and weight-lowering effects of liraglutide in mice

  2024cites this paper
• Molecular connectomics reveals a glucagon-like peptide 1-sensitive neural circuit for satiety

  2024cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024influential citation
• NMDA Receptors in POMC Neurons Connect Exercise With Insulin Sensitivity

  2024cites this paper
• Satiety: a gut–brain–relationship

  2024cites this paper
• Regulation of Energy and Glucose Homeostasis by the Nucleus of the Solitary Tract and the Area Postrema

  2024cites this paper
• Adequate sleep duration accentuates the effect of glucagon-like peptide-1 receptor variant on HbA1c: A gene-environment interaction study.

  2024cites this paper
• Selective Colocalization of GHSR and GLP-1R in a Subset of Hypothalamic Neurons and Their Functional Interaction.

  2024cites this paper
• The unexpected role of GIP in transforming obesity treatment.

  2024cites this paper
• Neurochemical Basis of Inter-Organ Crosstalk in Health and Obesity: Focus on the Hypothalamus and the Brainstem

  2023cites this paper
• Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.

  2023cites this paper
• [[Translated article]]Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.

  2023cites this paper
• A physiologic increase in brain glucagon action alters the hepatic gluconeogenic glycogenolytic ratio but not glucagon's overall effect on glucose production.

  2023cites this paper
• GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy

  2023cites this paper
• Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety

  2023cites this paper
• Homeostatic Regulation of Glucose Metabolism by the Central Nervous System

  2022cites this paper
• Mitochondria signaling pathways in allergic asthma

  2022cites this paper
• Paracrine actions of glucagon-like peptide 1 in the gut unraveled

  2022cites this paper
• MC4R biased signalling and the conformational basis of biological function selections

  2022cites this paper
• Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake

  2022cites this paper
• Glucagon-like peptide-1 receptor-based therapeutics for metabolic liver disease.

  2022influential citation
• A look on food intake and satiety: from humans to rodent models.

  2022cites this paper
• Glucose-sensing glucagon-like peptide-1 receptor neurons in the dorsomedial hypothalamus regulate glucose metabolism

  2022cites this paper
• Elevated Glucagon-like Peptide-1 Receptor Level in the Paraventricular Hypothalamic Nucleus of Type 2 Diabetes Mellitus Patients

  2022cites this paper
• Central NPFF signalling is critical in the regulation of glucose homeostasis

  2022cites this paper
• Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics

  2021influential citation
• Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo

  2021cites this paper
• Green alga Enteromorpha prolifera oligosaccharide ameliorates ageing and hyperglycemia through gut-brain axis in age-matched diabetic mice.

  2021cites this paper
• Central Nervous System (CNS)

  2021influential citation
• Effects of glucagon‐like peptide‐1 analogue treatment in genetic obesity: A case series

  2021cites this paper
• Divergent Effect of Central Incretin Receptors Inhibition in a Rat Model of Sporadic Alzheimer’s Disease

  2021cites this paper
• Dysregulation of IGF-1/GLP-1 signaling in the progression of ALS: potential target activators and influences on neurological dysfunctions

  2021cites this paper
• Holdemanella biformis improves glucose tolerance and regulates GLP‐1 signaling in obese mice

  2021cites this paper
• RF-amide related peptide-3 (RFRP-3): a novel neuroendocrine regulator of energy homeostasis, metabolism, and reproduction

  2021cites this paper
• Glucagon‐Like Peptide‐1 Receptor Activators

  2021cites this paper
• Nutrient infusion in the dorsal vagal complex controls hepatic lipid and glucose metabolism in rats

  2021cites this paper
• Hypothalamic Cell Models

  2021cites this paper
• Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control

  2021cites this paper
• Reframing appetitive reinforcement learning and reward valuation as effects mediated by hippocampal-dependent behavioral inhibition.

  2020cites this paper
• Olfactory bulb‐targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice

  2020cites this paper
• Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

  2020cites this paper
• Small intestinal metabolism is central to whole-body insulin resistance

  2020cites this paper
• GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats

  2020cites this paper
• Updating the Role of α-Cell Preproglucagon Products on GLP-1 Receptor–Mediated Insulin Secretion

  2020cites this paper
• Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats

  2020cites this paper
• Networking of glucagon-like peptide-1 axons with GnRH neurons in the basal forebrain of male mice revealed by 3DISCO-based immunocytochemistry and optogenetics

  2020cites this paper
• Glucagon-Like Peptide-1 Regulates the Proopiomelanocortin Neurons of the Arcuate Nucleus both Directly and Indirectly via Presynaptic Action

  2020cites this paper
• Peripheral and central regulation of insulin by the intestine and microbiome.

  2020cites this paper
• Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

  2020cites this paper
• Incretin Hormones and Type 2 Diabetes—Mechanistic Insights and Therapeutic Approaches

  2020cites this paper
• Brain insulin action: Implications for the treatment of schizophrenia.

  2020cites this paper
• GLP-1 mimetics and cognition.

  2020cites this paper
• Resistance Exercise Training Attenuates the Loss of Endogenous GLP-1 Receptor in the Hypothalamus of Type 2 Diabetic Rats

  2019cites this paper
• Appetite Regulation: Hormones, Peptides, and Neurotransmitters and Their Role in Obesity

  2019cites this paper
• Understanding the phenotype and preparing for therapeutics in Bardet-Biedl syndrome

  2019cites this paper
• Ghrelin regulation of glucose metabolism

  2019cites this paper
• The role of the preproglucagon neurons in cardiovascular control, energy homeostasis and glucose homeostasis

  2019cites this paper
• Glucagon, GLP-1 and Thermogenesis

  2019cites this paper
• Gastric Bypass Surgery Regulates Glucose Homeostasis Through the Hypothalamus

  2019cites this paper
• The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1

  2019cites this paper
• Exendin-4 antagonizes the metabolic action of acylated ghrelinergic signaling in the hypothalamic paraventricular nucleus.

  2019influential citation
• Blood-to-brain communication in the hypothalamus for energy intake regulation.

  2019cites this paper
• GLP-1: Molecular mechanisms and outcomes of a complex signaling system.

  2019cites this paper
• Is the Brain a Key Player in Glucose Regulation and Development of Type 2 Diabetes?

  2019cites this paper
• GLP-1 Limits Adipocyte Inflammation and Its Low Circulating Pre-Operative Concentrations Predict Worse Type 2 Diabetes Remission after Bariatric Surgery in Obese Patients

  2019cites this paper
• Effects of 17β estradiol and glucagon-like peptide-1 on gonadotropin-releasing hormone neurons in mice

  2018cites this paper
• Exenatide upregulates gene expression of glucagon‐like peptide‐1 receptor and nerve growth factor in streptozotocin/nicotinamide‐induced diabetic mice

  2018cites this paper
• Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?

  2018cites this paper
• Feeding and glucagon‐like peptide‐1 receptor activation stabilise β‐catenin in specific hypothalamic nuclei in male rats

  2018cites this paper
• Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function

  2018cites this paper
• Fasting glucagon-like peptide 1 concentration is associated with lower carbohydrate intake and increases with overeating

  2018cites this paper
• Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon‐like peptide 1 receptor agonists?

  2018cites this paper
• Ghrelin system signalling in appetite and reward: in vitro and in vivo perspectives

  2018cites this paper
• The Effect of Feeding Behavior on Hypothalamus in Obese Type 2 Diabetic Rats with Glucagon-like Peptide-1 Receptor Agonist Intervention

  2018cites this paper
• Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1.

  2018cites this paper
• Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.

  2018cites this paper
• Signalling from the periphery to the brain that regulates energy homeostasis

  2018cites this paper
• Intestinal peptide changes after bariatric and minimally invasive surgery: Relation to diabetes remission

  2018cites this paper
• GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice.

  2018cites this paper
• Loss of dorsomedial hypothalamic GLP-1 signaling reduces BAT thermogenesis and increases adiposity

  2018cites this paper
• Neuronal cAMP/PKA Signaling and Energy Homeostasis.

  2018cites this paper
• Corrigendum: Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides

  2018cites this paper
• Acute activation of GLP-1-expressing neurons promotes glucose homeostasis and insulin sensitivity

  2017cites this paper
• GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products

  2017cites this paper
• DREADDing proglucagon neurons: a fresh look at metabolic regulation by the brain.

  2017cites this paper
• Variable proopiomelanocortin expression in tanycytes of the adult rat hypothalamus and pituitary stalk

  2017cites this paper
• Activation of murine pre-proglucagon–producing neurons reduces food intake and body weight

  2017cites this paper